A total of three cohorts comparing PD patients with PRKN mutations to healthy controls were found, which referred to changes in the transcriptional levels from the skin fibroblasts, substantia nigra, caudate, and putamen biospecimen, respectively. Here, PRKN is linked to Parkinson disease.